Effect of Homocysteine-Lowering Therapy with Folic Acid, Vitamin B12 and Vitamin B6 on Clinical Outcome After Percutaneous Coronary Intervention
Plasma homocysteine level has been recognized as an important cardiovascular risk factor that predicts adverse cardiac events in patients with established coronary atherosclerosis and influences restenosis rate after percutaneous coronary intervention. Read More.
Plasma homocysteine level has been recognized as an important cardiovascular risk factor that predicts adverse cardiac events in patients with established coronary atherosclerosis and influences restenosis rate after percutaneous coronary intervention. Read More.